How Neuropeptides Like CGRP and Substance P Cause Orthodontic Pain and May Also Control Tooth Movement
Neuropeptides including CGRP and substance P mediate orthodontic pain through TRPV1-expressing nociceptors in the periodontium, and these same nerve fibers may also regulate the bone remodeling that enables tooth movement.
Quick Facts
What This Study Found
TRPV1-expressing periodontal nociceptors release neuropeptides (CGRP, substance P) that mediate orthodontic pain and may also regulate alveolar bone remodeling during tooth movement, creating a dual neuroskeletal interaction.
Key Numbers
Neuropeptides including CGRP and substance P identified as dual mediators of orthodontic pain and bone remodeling.
How They Did This
Review article synthesizing research on nociceptor mechanisms in orthodontic pain, covering molecular transducers (TRPV1, TRPA1, ASIC3, P2X3), neuropeptide signaling (CGRP, substance P), and the potential neuroskeletal interactions between pain-sensing nerves and bone remodeling.
Why This Research Matters
Orthodontic pain affects millions of patients and is the leading cause of treatment discontinuation. Understanding that neuropeptides both cause the pain and influence tooth movement means we could develop targeted therapies that reduce pain while preserving — or even accelerating — the desired tooth movement.
The Bigger Picture
Anti-CGRP antibodies have revolutionized migraine treatment, and this review suggests a parallel opportunity in dentistry. If CGRP and substance P both drive orthodontic pain and modulate bone remodeling, targeting these neuropeptides could fundamentally change orthodontic practice — reducing pain, improving patient compliance, and potentially accelerating treatment. The concept of 'no pain, big gain' could become achievable through neuropeptide-targeted interventions.
What This Study Doesn't Tell Us
Review article — most evidence comes from animal models. The relationship between nociceptors and bone remodeling in orthodontics is hypothesized but not yet proven in clinical settings. Blocking neuropeptides to reduce pain could potentially slow tooth movement if the neuroskeletal coupling is confirmed. Individual pain sensitivity varies widely.
Questions This Raises
- ?Would anti-CGRP or anti-substance P treatments reduce orthodontic pain without slowing tooth movement?
- ?Could neuropeptide modulation be used to both reduce pain AND accelerate tooth movement simultaneously?
- ?Why do some patients experience significantly more orthodontic pain than others — is it related to neuropeptide expression levels?
Trust & Context
- Key Stat:
- Dual neuroskeletal role CGRP and substance P from periodontal nociceptors both drive orthodontic pain AND may regulate the bone remodeling needed for tooth movement — a potential therapeutic target
- Evidence Grade:
- Moderate — well-reasoned review synthesizing established nociceptor biology with emerging evidence on neuroskeletal interactions in orthodontics. Many hypotheses remain to be tested clinically.
- Study Age:
- Published in 2024, presenting a current perspective on molecular mechanisms of orthodontic pain and neuroskeletal interactions.
- Original Title:
- Nociceptor mechanisms underlying pain and bone remodeling via orthodontic forces: toward no pain, big gain.
- Published In:
- Frontiers in pain research (Lausanne, Switzerland), 5, 1365194 (2024)
- Authors:
- Wang, Sheng(2), Ko, Ching-Chang, Chung, Man-Kyo(2)
- Database ID:
- RPEP-09483
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
Why do braces hurt so much?
When braces push on teeth, they compress and stretch the tissues around teeth (periodontium), triggering inflammation. This inflammation activates pain-sensing nerve endings that release neuropeptides like CGRP and substance P, which amplify the pain signal and cause more inflammation — creating a cycle. The intensity of this cycle varies between people based on individual differences in their nerve sensitivity and neuropeptide levels.
Could migraine drugs help with orthodontic pain?
Potentially yes — both migraine and orthodontic pain involve the same neuropeptide CGRP acting through similar nerve pathways (the trigeminal system). Anti-CGRP drugs that are already approved for migraine could theoretically reduce orthodontic pain. However, researchers first need to confirm that blocking CGRP won't interfere with the bone remodeling process that actually moves teeth, since the same neuropeptide may play a role in both.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09483APA
Wang, Sheng; Ko, Ching-Chang; Chung, Man-Kyo. (2024). Nociceptor mechanisms underlying pain and bone remodeling via orthodontic forces: toward no pain, big gain.. Frontiers in pain research (Lausanne, Switzerland), 5, 1365194. https://doi.org/10.3389/fpain.2024.1365194
MLA
Wang, Sheng, et al. "Nociceptor mechanisms underlying pain and bone remodeling via orthodontic forces: toward no pain, big gain.." Frontiers in pain research (Lausanne, 2024. https://doi.org/10.3389/fpain.2024.1365194
RethinkPeptides
RethinkPeptides Research Database. "Nociceptor mechanisms underlying pain and bone remodeling vi..." RPEP-09483. Retrieved from https://rethinkpeptides.com/research/wang-2024-nociceptor-mechanisms-underlying-pain
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.